Home / Stocks / MDT

Medtronic (MDT, Health Care Equipment) Stock Valuation & Fair Value Fairly valued

Medtronic (MDT, Health Care Equipment) trades at a blended P/E of 16.3, about 3% below its historical normal valuation, with a forward growth estimate of 8.0% and a PEG of 2.03. Analysts' one-year estimates have been hit 82% of the time.

DATA AS OF 2026-08-21
Blended P/E
16.3
Normal P/E
16.8
PEG
2.03
Fwd growth
8.0%
Div yield
3.1%
RSI (14)
70.7
Overbought

The Street vs SeerForecast

Wall Street's mean price target for MDT is $98.44 across 25 analysts, 5.5% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: fairly valued. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from quality business with a solid forward outlook (2026-06-03) to fairly valued (2026-08-21).

Price and rating by weekClose moved +18.1 percent from 2026-06-03 to 2026-08-17, with 1 rating change over 21 recorded weeks.2026-06-03: Quality business with a solid forward outlook, close 77.25 (recalculated)2026-06-10: Quality business with a solid forward outlook, close 79.53 (recalculated)2026-06-14: Quality business with a solid forward outlook, close 79.48 (recalculated)2026-06-16: Quality business with a solid forward outlook, close 80.59 (recalculated)2026-06-21: Quality business with a solid forward outlook, close 78.63 (recalculated)2026-07-02: Quality business with a solid forward outlook, close 83.19 (recalculated)2026-07-06: Quality business with a solid forward outlook, close 83.06 (recalculated)2026-07-09: Quality business with a solid forward outlook, close 82.39 (recalculated)2026-07-12: Quality business with a solid forward outlook, close 83.87 (recalculated)2026-07-13: Quality business with a solid forward outlook, close 83.57 (recalculated)2026-07-14: Quality business with a solid forward outlook, close 79.30 (recalculated)2026-07-20: Quality business with a solid forward outlook, close 83.29 (recalculated)2026-07-22: Quality business with a solid forward outlook, close 81.89 (recalculated)2026-07-25: Quality business with a solid forward outlook, close 83.21 (recalculated)2026-07-27: Quality business with a solid forward outlook, close 84.22 (recalculated)2026-07-31: Quality business with a solid forward outlook, close 85.39 (recalculated)2026-08-03: Quality business with a solid forward outlook, close 85.392026-08-07: Quality business with a solid forward outlook, close 87.16 (recalculated)2026-08-10: Fairly valued, close 87.162026-08-14: Fairly valued, close 91.27 (recalculated)2026-08-17: Fairly valued, close 91.2777912026-06-032026-08-17
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

2026-06-03P/E 13.6-22%Quality business with a solid forward outlook
2026-06-10P/E 14.7-13%Quality business with a solid forward outlook
2026-06-14P/E 14.7-13%Quality business with a solid forward outlook
2026-06-16P/E 14.7-13%Quality business with a solid forward outlook
2026-06-21P/E 14.7-13%Quality business with a solid forward outlook
2026-07-02P/E 14.1-16%Quality business with a solid forward outlook
2026-07-06P/E 14.8-11%Quality business with a solid forward outlook
2026-07-09P/E 14.8-11%Quality business with a solid forward outlook
2026-07-12P/E 14.9-11%Quality business with a solid forward outlook
2026-07-13P/E 14.9-11%Quality business with a solid forward outlook
2026-07-14P/E 14.9-11%Quality business with a solid forward outlook
2026-07-20P/E 14.8-12%Quality business with a solid forward outlook
2026-07-22P/E 14.8-12%Quality business with a solid forward outlook
2026-07-25P/E 14.8-12%Quality business with a solid forward outlook
2026-07-27P/E 14.8-12%Quality business with a solid forward outlook
2026-07-31P/E 15.2-9%Quality business with a solid forward outlook
2026-08-03P/E 15.2-10%Quality business with a solid forward outlook
2026-08-07P/E 15.2-9%Quality business with a solid forward outlook
2026-08-10P/E 15.4-8%Fairly valued
2026-08-14P/E 16.0-4%Fairly valued
2026-08-17P/E 16.1-4%Fairly valued
2026-08-21P/E 16.3-3%Fairly valued ← now

Frequently asked questions

Is Medtronic stock overvalued?

At a blended P/E of 16.3 versus its historical normal P/E of 16.8, Medtronic trades about 3% below its typical valuation, with a PEG of 2.03 on 8.0% forward growth. tickerseer currently rates it fairly valued.

What is Medtronic's fair value and PEG?

Medtronic trades at a blended P/E of 16.3 against a historical normal P/E of 16.8, a PEG of 2.03, and a forward growth estimate of 8.0%.

Has tickerseer's rating of Medtronic changed?

tickerseer's rating moved from quality business with a solid forward outlook (2026-06-03) to fairly valued (2026-08-21).

What is the analyst price target for Medtronic?

The mean Wall Street price target for Medtronic is $98.44 across 25 analysts, 5.5% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Health Care Equipment. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track MDT free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. Educational content, not investment advice.